Monocytosis and Clonal Hematopoiesis in Peripheral Blood as Indicators of Myeloid Neoplasm in Erdheim-Chester Disease

Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Background: Erdheim-Chester disease (ECD) is a rare non-Langerhans histiocytosis, with similar to 10% of cases showing myeloid neoplasms (MNs). Methods: A 70-year-old woman with cardiac arrhythmia and right atrial mass was diagnosed with ECD by biopsy. Complete blood count showed persistent monocytosis. Targeted next-generation sequencing (NGS) of peripheral blood (PB) for evaluating clonal hematopoiesis (CH) was performed.<br /> Results: The NGS revealed ASXL1 Asn893Cysfs*12 (variant allele frequency [VAF]: 37.2%), TET2 His1031 Glnfs*11 (VAF: 49.0%) and TET2 Tyr1255* (VAF: 47.5%). Bone marrow examination confirmed concomitant chronic myelomonocytic leukemia.<br /> Conclusions: NGS using PB needs to be considered in ECD for the detection of CH and for the diagnosis of coexisting MNs.

키워드

Erdheim-Chester disease; clonal hematopoiesis; chronic myelomonocytic leukemia; TET2; ASXL1; HEALTH-ORGANIZATION CLASSIFICATION
제목
Monocytosis and Clonal Hematopoiesis in Peripheral Blood as Indicators of Myeloid Neoplasm in Erdheim-Chester Disease
저자
Park, Chang-Hun; Yu, SooHo; Lee, Ki-O; Yoon, Sang Eun; Kim, Hyun-Young; Kim, Hee-Jin
DOI
10.7754/Clin.Lab.2025.250912
발행일
2026-07
유형
Article
저널명
Clinical Laboratory
권
72
호
7
페이지
1590 ~ 1594